Posted on

Law & Ethics: The Psychedelics Industry & Indigenous Peoples, A PBA Four-Part Series – Psychedelic Bar Association

Ever wondered what happens when you mix an Italian anthropologist, a mycologist with a Mohawk heritage, the last captive of the Comanches, an attorney specializing in psychedelic law, and a restorative justice wizard from DC? No, it’s not the start of a bar joke; it’s a powerhouse panel!

**Riccardo Vitale** is the Indiana Jones of anthropology, but instead of hunting treasures, he’s been navigating the human rights and climate change jungle in Latin America for 15 years. When he’s not advising the Union of Indigenous Yagé Medics in the Amazon, he’s probably chatting about his PhD from Cambridge.

**Keith Williams** is the mushroom whisperer you never knew you needed. With a PhD in educational studies and an M.Sc. in mycology, this Haudenosaunee (Mohawk) descendant is the Director of Research and Social Innovation at Ontario’s First Nations Technical Institute. His mission? To blend humanity’s relationship with nature, psychedelics, and traditional knowledge into a cocktail of wisdom.

**Troy Sia** might just be the coolest title holder around: the Last Captive of the Comanches. As an Eagle Priest and founder of the Sia Comanche Nation Ethno-Ornithological Initiative, he’s keeping the spirit and culture of the Comanche people soaring high while advocating for environmental action and restorative governance.

**Ariel Clark**, co-founder of Clark Howell LLP, is the legal eagle in the psychedelic and cannabis skies. She’s also a co-founder of the Psychedelic Bar Association and a UC Berkeley JD holder, battling for law reform and ethical business.

**Roman Haferd** is the justice league’s real-life hero in Washington DC, focusing on restorative justice

Reference: https://thepsychedelicbar.org/law-ethics-the-psychedelics-industry-indigenous-peoples-a-pba-four-part-series/

Published Date: None

Posted on

The DEA is no longer banning these drugs

In January, the DEA proposed to ban 5 psychedelic drugs (4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET, and DiPT) by classifying them as Schedule I substances.

After receiving significant pushback, the DEA has withdrawn the proposal.

Instead, the agency is requesting for the Department of Health and Human Services to conduct scientific and medical evaluations of the drugs to guide scheduling recommendations.

read more

Posted on

This study could be a game changer

A new government-funded study will see if psilocybin can ease depression without producing a psychedelic effect – and no, we aren’t talking about microdosing…

At Toronto’s Centre for Addiction and Mental Health, adults with treatment-resistant depression will receive a full dose of psilocybin + 12 hours of therapy. 

What makes this study unique is that some patients will also receive a serotonin blocker, which will block the psychedelic or hallucinogenic effects of the psilocybin.

If benefits can be delivered while avoiding the trip, this could open up psilocybin therapy to those who aren’t typically candidates for the treatment, as well as people who don’t want to hallucinate. 

Learn how you can participate in the study here

Posted on

First Phase 3 trial receives government funding

After receiving three ketamine therapy sessions in Awakn’s Phase 2 trial, patients with alcohol use disorder achieved an increase in abstinence from around 2% to 86%. This means they abstained from alcohol for an average of 162 of the 180 days following the treatment 👏

The results were so encouraging that the UK government granted the company CA$2.5M to fund Phase 3 of the trial.

The grant covers two-thirds of Awakn’s costs and marks the first time that a Phase 3 psychedelics trial has received government funding.

With 280 patients across 7 sites in the UK, it will be the largest ketamine-assisted therapy trial to date!

read more

Posted on

2 years til medical legalization!

FDA approval of MDMA for PTSD and psilocybin for depression is anticipated within the next 24 months, according to a letter from the Department of Health and Human Services.

The department is also considering starting a federal task force dedicated to addressing complex issues surrounding psychedelics such as harm reduction and safety.

“Too many Americans are suffering from mental health and substance use issues, which have been exacerbated by the ongoing COVID-19 pandemic, and that we must explore the potential of psychedelic-assisted therapies to address this crisis,” the letter explains.

read more here

Posted on

The Trip of a Lifetime

DOSED 2 Screening with Dr. Gabor Maté & Dennis McKenna Q&A

Mark your calendar – DOSED 2: The Trip of a Lifetime is coming to the Vogue Theatre in Vancouver on  August 3rd! 

If you haven’t seen the original DOSED, check it out here. The award-winning documentary follows a woman overcoming opioid addiction with psilocybin and iboga.

DOSED 2 shares the remarkable story of a terminally-ill cancer patient who was granted the right to try psilocybin mushrooms to treat her end of life anxiety.

The special event premiere screening will be followed by an audience Q&A with:

  • Renowned addiction expert and author Dr. Gabor Maté
  • Legendary psychonaut Dennis McKenna
  • Psychedelic therapist (and your fave Daily Mushroom Podcast guest) Dave Phillips
  • Patient Laurie Brooks
  • Filmmakers Tyler Chandler & Nicholas Meyers
  • And more!

Get screening tickets

Watch the DOSED 2 trailer

Posted on

An athlete’s take on microdosing

Microdosing Mushrooms: Athlete Perspectives on the Psychedelic Supplement

A tiny dose of magic mushrooms might help you improve your form in the gym.

According to jiu jitsu athlete Adam Hanna, microdosing before a workout could help you focus on mind-body connection to better understand your body’s movement patterns.

“You are learning to do the same moves while under different states of consciousness, which helps you feel very small details,” he explains.

“Example: Exactly where my weight is in my fingers in a handstand. Is there enough weight in my thumb and index finger? You can hone in on stuff like this. It can help you really focus exclusively on tiny details that you don’t always think to do when sober.”

PDF of article

Posted on

US military to study psychedelic therapy?

GOP Congressman’s Amendment Would Direct Military To Study Psilocybin And MDMA Benefits For Service Members

Last week, an amendment calling for the Department of Defense (DOD) to study medical cannabis for military service members was approved by a House Committee.

Now, Rep. Matt Gaetz (R-FL) is pushing for the amendment to be expanded to include psilocybin and MDMA. If approved the DOD would be required to study the therapeutic potential of the drugs as alternatives to opioids prescribed for chronic pain.

PDF of article

Posted on

Colorado to vote on psilocybin measure this Fall!

Colorado Activists Turn In Signatures To Put Psychedelics Legalization And Therapeutic Psilocybin Program On Ballot

After Colorado activists submitted nearly twice the amount of signatures required, the Natural Medicine Health Act will appear on the ballot this November!

Colorado residents will vote to legalize possession of certain psychedelics and implement a model for legal psilocybin treatments, similar to Oregon’s.

PDF of article